Medicenna Therapeutics Corp (MDNAF)

Medicenna Therapeutics Statistics

Total Valuation

MDNAF has a market cap or net worth of $227.09 million. The enterprise value is $197.48 million.

Market Cap	227.09M
Enterprise Value	197.48M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

MDNAF has 69.64 million shares outstanding. The number of shares has increased by 24.06% in one year.

Shares Outstanding	69.64M
Shares Change (YoY)	+24.06%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	33.13%
Owned by Institutions (%)	n/a
Float	32.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.44
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.74, with zero debt.

Current Ratio	9.74
Quick Ratio	9.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.40% and return on invested capital (ROIC) is -61.09%.

Return on Equity (ROE)	-28.40%
Return on Assets (ROA)	-23.50%
Return on Capital (ROIC)	-61.09%
Revenue Per Employee	n/a
Profits Per Employee	-$1.25M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +92.18% in the last 52 weeks. The beta is 0.71, so MDNAF's price volatility has been lower than the market average.

Beta (1Y)	0.71
52-Week Price Change	+92.18%
50-Day Moving Average	1.03
200-Day Moving Average	0.51
Relative Strength Index (RSI)	49.10
Average Volume (30 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.43M
Pretax Income	-8.76M
Net Income	-8.76M
EBITDA	-8.75M
EBIT	-8.76M
Earnings Per Share (EPS)	-$0.13

Balance Sheet

The company has $29.62 million in cash and no debt, giving a net cash position of $29.62 million or $0.43 per share.

Cash & Cash Equivalents	29.62M
Total Debt	n/a
Net Cash	29.62M
Net Cash Per Share	$0.43
Equity / Book Value	26.90M
Book Value Per Share	0.39
Working Capital	28.25M

Cash Flow

Operating Cash Flow	-13.82M
Capital Expenditures	n/a
Free Cash Flow	-13.82M
FCF Per Share	-$0.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MDNAF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.06%
Shareholder Yield	-24.06%
Earnings Yield	-3.86%
FCF Yield	-6.09%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1